Cargando…

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight

The pathogenesis of type 2 diabetes (T2D) involves chronic hyperinsulinemia due to systemic and hepatic insulin resistance (IR), which if uncorrected, will lead to progressive pancreatic beta cell failure in predisposed individuals. Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ballestri, Stefano, Nascimbeni, Fabio, Romagnoli, Dante, Baldelli, Enrica, Targher, Giovanni, Lonardo, Amedeo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813216/ https://www.ncbi.nlm.nih.gov/pubmed/27005620 http://dx.doi.org/10.3390/ijms17030355

Ejemplares similares

NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk
por: Ballestri, Stefano, et al.
Publicado: (2017)

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
por: Lonardo, Amedeo, et al.
Publicado: (2016)

Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease
por: Ballestri, Stefano, et al.
Publicado: (2021)

Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?
por: Nascimbeni, Fabio, et al.
Publicado: (2018)

Alcohol and Steatosis: The Japanese Paradox
por: Lonardo, A., et al.
Publicado: (2016)

Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis
por: Rinaldi, Luca, et al.
Publicado: (2017)

Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review
por: Ballestri, Stefano, et al.
Publicado: (2020)

Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
por: Mantovani, Alessandro, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease: Evolving paradigms
por: Lonardo, Amedeo, et al.
Publicado: (2017)

Methodological Tools for Exploring Novel Biopharmaceutical Approaches to the Metabolic Syndrome and Related Disorders: A Commentary on: Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. A Focus on Early Phase Clinical Drug Development, Second Edition
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
por: Lonardo, Amedeo, et al.
Publicado: (2022)

Gamma glutamyl transferase: A novel cardiovascular outfit for an old liver test
por: Lonardo, Amedeo, et al.
Publicado: (2016)

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
por: Mantovani, Alessandro, et al.
Publicado: (2021)

Neutrophils: Musketeers against immunotherapy
por: Zahid, Kashif Rafiq, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure
por: Inciardi, Riccardo M., et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure
por: Valbusa, Filippo, et al.
Publicado: (2016)

Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
por: Rios, Rafael S., et al.
Publicado: (2020)

NAFLD: Is There Anything New under the Sun?
por: Lonardo, Amedeo, et al.
Publicado: (2017)

History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease
por: Nascimbeni, Fabio, et al.
Publicado: (2016)

What’s Past Is Prologue: History of Nonalcoholic Fatty Liver Disease
por: Targher, Giovanni
Publicado: (2020)

Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena?
por: Lonardo, Amedeo
Publicado: (2022)

Disagreement among the three musketeers of the unfolded protein response
por: Jipa, András, et al.
Publicado: (2023)

Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis
por: Maurelli, Martina, et al.
Publicado: (2023)

Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
por: Tana, Claudio, et al.
Publicado: (2019)

Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum
por: Tavaglione, Federica, et al.
Publicado: (2020)

Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease
por: Zhang, Xin-Lei, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease Is Associated with an Increased Incidence of Atrial Fibrillation in Patients with Type 2 Diabetes
por: Targher, Giovanni, et al.
Publicado: (2013)

Case of Lodgement of a Musket-Ball in the Left Ventricle of the Heart
Publicado: (1854)

Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review
por: Miao, Lei, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease – a growing public health problem
por: Mikolašević, Ivana, et al.
Publicado: (2021)

NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management
por: Lonardo, Amedeo, et al.
Publicado: (2019)

Nerve Imaging, Electrodiagnostics, and Clinical Examination — Three Musketeers to Differentiate Polyneuropathies
por: Winter, Natalie, et al.
Publicado: (2022)

The Trypanosoma cruzi Sylvio X10 strain maxicircle sequence: the third musketeer
por: Ruvalcaba-Trejo, Laura I, et al.
Publicado: (2011)

Structure and Function of Parkin, PINK1, and DJ-1, the Three Musketeers of Neuroprotection
por: Trempe, Jean-François, et al.
Publicado: (2013)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020)

Non‐alcoholic fatty liver disease in patients with autoimmune hepatitis
por: Takahashi, Atsushi, et al.
Publicado: (2018)

Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
por: Lin, Cheng-Jie, et al.
Publicado: (2018)

Challenges in the hepatic histopathology in non-alcoholic fatty liver disease
por: Brunt, Elizabeth M, et al.
Publicado: (2017)

Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers
por: Sanna, Claudia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hu127s65nbbilr1lctf5595efq